Board meeting on October 30, 2026 to consider unaudited Q2 and half-year results
The company has informed the exchanges that a meeting of its Board of Directors is scheduled for Friday, October 30, 2026.
By ScoutQuest · · 2 min read
- Board Meeting Date
- Friday, October 30, 2026
- Results Period
- second quarter and half year ended September 30, 2026
- Trading Window Closure
- closed till Sunday, November 01, 2026
What the company has informed the exchanges
- A meeting of the Board of Directors is scheduled to be held on Friday, October 30, 2026.
- At this meeting, the board will consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the company for the second quarter and half year ended September 30, 2026.
- Other business(es) will also be taken up.
Why quarterly results matter
Results are the periodic scorecard a listed company publishes, showing how the business has performed over a defined period. The period covered here is the second quarter and the half year ended September 30, 2026.
The update covers two sets of numbers. Standalone results reflect the company on its own, while consolidated results reflect the company together with its subsidiaries. Investors often look at both to understand the full picture of the business.
The meeting also covers the half year, not just the quarter, so it captures performance for the first six months of the financial year.
Trading window closure
- The Trading Window for dealing in the securities of the company will remain closed till Sunday, November 01, 2026.
- This follows the company's earlier letter dated September 28, 2026.
A trading window closure means that designated persons connected with the company are not permitted to buy or sell its shares during that period. It is meant to ensure that people with access to unpublished price-sensitive information, such as the financial results, do not trade on it before everyone else can see it. The window generally reopens once the results are made public.
What to note as an investor
The update is an intimation that a board meeting has been scheduled; it does not itself contain any financial figures. The results themselves will be considered and approved at the meeting on October 30, 2026, and the outcome of the meeting will be communicated separately.
Also from Corona Remedies
Corona Remedies Ltd press release
22 Oct 2026
ANVISA GMP certification received for OSD and Hormone facilities at Bhayla, Ahmedabad
22 Oct 2026
Corona Remedies to hold Q2 FY27 earnings conference call on November 02, 2026 at 11:30 a.m. IST
16 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.